Skip to content

Genetic Counseling and Lifestyle Change for Diabetes Prevention

Genetic Counseling and Lifestyle Change for Diabetes Prevention

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01034319
Acronym
GC/LC
Enrollment
90
Registered
2009-12-17
Start date
2009-12-31
Completion date
2012-12-31
Last updated
2011-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Overweight, Pre-diabetes

Keywords

type 2 diabetes, genetics, genetic counseling, diabetes prevention

Brief summary

This study will examine the impact diabetes genetic counseling on patient motivation and disease prevention behaviors among subjects with pre-diabetes. Intervention subjects will be provided with their individual diabetes genotype risk score derived from aggregating the combined results of 37 diabetes risk-associated genetic loci. Controls will not be tested. All subjects will be enrolled in a 12-week diabetes prevention program.

Detailed description

This study will examine the impact diabetes genetic counseling on patient motivation and disease prevention behaviors among subjects with pre-diabetes. We will randomize subjects with pre-diabetes to genetic testing vs. no genetic testing in order to obtain an unconfounded test of the hypothesis that genetic testing will change patient behavior. Intervention subjects will be provided with their individual diabetes genotype risk score derived from aggregating the combined results of 37 diabetes risk-associated genetic loci. Because patients can receive either Higher risk or Lower risk genetic test results, we will separately examine the impact of Higher risk and Lower risk test results compared to untested controls. All subjects will be enrolled in a 12-week diabetes prevention program.

Interventions

BEHAVIORALDiabetes Genetic Counseling

Subjects will be genotyped based on a 37-allele aggregate score and counseled regarding the implications of the results prior to enrollment in a 12-week diabetes prevention program

BEHAVIORALNo genetic counseling

These subjects will not be genotyped or counseled prior to enrollment in a 12-week diabetes prevention program

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Overweight (Body mass index ≥ 29.1 kg/m2 in men, ≥ 27.2 kg/m2 in women) with at least 2 other formal criteria for Metabolic Syndrome (see Table -NCEP ATP-III Criteria) * Adult (\> 21 years of age) * No diagnosis or treatment for diabetes (Type 1 or Type 2) or cardiovascular disease (e.g. myocardial infraction, coronary bypass surgery, congestive heart failure, peripheral vascular disease) * Physically able and willing to participate in a 12-week group session curriculum for weight loss and dietary change * Able to understand and communicate effectively in English

Design outcomes

Primary

MeasureTime frame
stage of changebaseline, after counseling, after completing program (3 months)

Secondary

MeasureTime frame
program attendance3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026